IMVT vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Microsoft Corp in 2026
IMVT
Immunovant Inc
$24.50
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | IMVT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $5.22B | N/A | IMVT |
| P/E Ratio | N/A | 23.21 | MSFT |
| EPS (TTM) | $N/A | $15.98 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze IMVT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or MSFT a better investment?
Comparing IMVT and MSFT: Immunovant Inc has a market cap of $5.22B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and MSFT?
IMVT (Immunovant Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for IMVT.
Which company is more profitable: IMVT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for IMVT.
Which is the larger company: IMVT or MSFT?
Immunovant Inc (IMVT) is larger with a market cap of $5.22B compared to N/A for MSFT.
Should I buy IMVT or MSFT in 2026?
Both IMVT and MSFT have investment merit. IMVT trades at $24.50 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and MSFT stock?
Key differences: Market Cap ($5.22B vs N/A), P/E Ratio (N/A vs 23.2x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).